EUVIMEDEUVIMED entdecken
Crossref

CRISPR-Cas9 based knockout of S100A8 in mammary epithelial cells enhances cell proliferation and triggers oncogenic transformation via the PI3K-Akt pathway: Insights from a deep proteomic analysis

Parul Singh, Syed Azmal Ali, Sudarshan Kumar, Ashok Kumar Mohanty

Journal of Proteomics · 2023

DOI: 10.1016/j.jprot.2023.104981 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Proteomics, 2023. Verfasst von Parul Singh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Proteomics and Cell Biology Lab, Animal Biotechnology Center, National Dairy Research Institute, Karnal, 132001, Haryana, India. Hauptthemen laut MEDLINE: Calgranulin A, Phosphatidylinositol 3-Kinases, Proto-Oncogene Proteins c-akt, Carcinogenesis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 76 Literaturangaben. Gefördert von: Department of Biotechnology, Ministry of Science and Technology, India, National Drug Research Institute, Deutsches Krebsforschungszentrum.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

S100A8 is a calcium-binding protein with multiple functions, including being a chemoattractant for phagocytes and playing a key role in the inflammatory response. Its expression has been shown to influence epithelial-mesenchymal transition (EMT) and metastasis in colorectal cancer. However, the role of S100A8 in cell proliferation and differentiation remains unknown. In this study, we used the CRISPR-Cas9 system to knock out S100A8 in healthy mammary epithelial cells and investigated the resulting changes in proteome profiling and signaling pathways. Our results showed that S100A8 knockout led to an increase in cell proliferation and migration, reduced cell-cell adhesion, and increased apoptosis compared to wildtype cells. Proteomics data indicated that S100A8 significantly affects cell cycle progression, cell proliferation, and cell survival through the PI3K-Akt pathway. Furthermore, our findings suggest that S100A8 function is associated with Pten expression, a negative regulator of the PI3K-Akt pathway. These results indicate that S100A8 dysregulation in healthy cells can lead to altered cellular physiology and higher proliferation, similar to cancerous growth. Therefore, maintaining S100A8 expression is critical for preserving healthy cell physiology. This study provides novel insights into the role of S100A8 in cell proliferation and differentiation and its potential relevance to cancer biology. SIGNIFICANCE: The study suggests that maintaining S100A8 expression is critical for preserving healthy cell physiology, and dysregulation of S100A8 in healthy cells can lead to altered cellular physiology and higher proliferation, similar to cancerous growth. Therefore, targeting the PI3K-Akt pathway or regulating Pten expression, a negative regulator of the PI3K-Akt pathway, may be potential strategies for cancer treatment by controlling S100A8 dysregulation. Additionally, S100A8 and S100A9 have been shown to promote metastasis of breast carcinoma by forming a metastatic milieu. However, the differential expression of S100A8 in tumors and its dual effects of antitumor and protumor make the relationship between S100A8 and tumors complicated. Currently, most research focuses on the function of S100A8 as a secretory protein in the microenvironment of tumors, and its function inside healthy cells without forming dimers remains unclear. Furthermore, the study provides insight into the role of S100A8 in cell proliferation and differentiation, which may have implications for other diseases beyond cancer. The functional role of S100A8 in normal mammary epithelial cells remains completely uncertain. Therefore, the objective of this study is to investigate the function of S100A8 on proliferation in mammary epithelial cells after its deletion and to elucidate the underlying proteins involved in downstream signaling. Our findings indicate that the deletion of S100A8 leads to excessive proliferation in normal mammary epithelial cells, reduces apoptosis, and affects cell-cell adhesion molecules required for cellular communication, resulting in a cancer-like phenotype.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Calgranulin APhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktCarcinogenesisHumansCell Line, TumorCell MovementCell ProliferationCRISPR-Cas SystemsEpithelial CellsEpithelial-Mesenchymal TransitionProteomicsGene Knockout Techniques

Stichwörter der Autor:innen

ApoptosisCRISPRCell cycleMammary epithelial cellProliferationProteomicsS100A8S100A9

Substanzen

Calgranulin APhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-akt

Autor:innen und Institutionen

  • Proteomics and Cell Biology Lab, Animal Biotechnology Center, National Dairy Research Institute, Karnal, 132001, Haryana, India.
  • Proteomics and Cell Biology Lab, Animal Biotechnology Center, National Dairy Research Institute, Karnal, 132001, Haryana, India; Proteomics of Stem Cells and Cancer, German Cancer Research Center, 69120 Heidelberg, Germ…
  • Proteomics and Cell Biology Lab, Animal Biotechnology Center, National Dairy Research Institute, Karnal, 132001, Haryana, India; Indian Veterinary Research Institute, Mukteshwar, 263138 Nainital, Uttarakhand, India. Ele…

Förderung

  • Department of Biotechnology, Ministry of Science and Technology, India
  • National Drug Research Institute
  • Deutsches Krebsforschungszentrum

Zitieren

APA

Singh, P., Ali, S. A., Kumar, S., & Mohanty, A. K. (2023). CRISPR-Cas9 based knockout of S100A8 in mammary epithelial cells enhances cell proliferation and triggers oncogenic transformation via the PI3K-Akt pathway: Insights from a deep proteomic analysis. Journal of Proteomics. https://doi.org/10.1016/j.jprot.2023.104981

Vancouver

Singh P, Ali SA, Kumar S, Mohanty AK. CRISPR-Cas9 based knockout of S100A8 in mammary epithelial cells enhances cell proliferation and triggers oncogenic transformation via the PI3K-Akt pathway: Insights from a deep proteomic analysis. Journal of Proteomics. 2023. doi:10.1016/j.jprot.2023.104981

BibTeX
@article{Singh2023,
  author = {Singh, Parul and Ali, Syed Azmal and Kumar, Sudarshan and Mohanty, Ashok Kumar},
  title = {CRISPR-Cas9 based knockout of S100A8 in mammary epithelial cells enhances cell proliferation and triggers oncogenic transformation via the PI3K-Akt pathway: Insights from a deep proteomic analysis},
  journal = {Journal of Proteomics},
  year = {2023},
  doi = {10.1016/j.jprot.2023.104981}
}
Kostenlos starten →